ScottsMiracle-Gro reported a 5% increase in net sales to $1.46 billion and improved gross margin rates by over 200 basis points in Q2 2026, driving an 18% rise in GAAP EPS to $4.46. The company also reduced its net leverage ratio to 3.71x from 4.41x the previous year, supporting its ongoing share repurchase program. Management reaffirmed its fiscal 2026 outlook, expecting continued sales growth, margin expansion, and free cash flow improvements. Strong sales momentum into April further boosts confidence in meeting full-year financial targets.
A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
Klarna benefits from maturing financing cohorts, low-cost deposit funding, and prudent risk management, leading to increased transaction margins and net interest income. This supports their growth strategy, reflected in accelerating gross merchandise...
Goldman Sachs reported robust Q2 FY2026 results, with net earnings growing at an annualized rate of 38%. The firm raised $31 billion in private credit and saw a 130% year-over-year surge in equity underwriting revenues, driven by major deals and IPO ...
